Ronald D. Vale, PhD, professor of cellular and molecular pharmacology at UCSF, has been named executive director of the Janelia Research Campus of the Howard Hughes Medical Institute and an HHMI vice president, effective in early 2020.
A program offering group support, acupuncture, mindfulness, massage and gentle exercise may help prevent patients on prescription opioids from spiraling down to drug misuse, overdose and death.
The gift established the endowed Jere E. Goyan Presidential Chair for the Advancement of Pharmacy, which honors the longest-serving dean of the School of Pharmacy.
UCSF scientists have used the CRISPR-Cas9 gene-editing system to create the first pluripotent stem cells that are functionally “invisible” to the immune system.
A personal survey of patients with AF has found that the majority of triggers for the condition are easily modifiable lifestyle choices, including alcohol, caffeine, exercise and lack of sleep.
UCSF Fresno recently received contributions of more than $1 million from two development companies and families known for giving back to the local community.
Scientists at UCSF, in collaboration with colleagues at UNC, have developed the world’s largest virtual pharmacology platform and shown it is capable of identifying extremely powerful new drugs.
Hana El-Samad’s research may one day make it possible to take a broken cell and bring it back to health by dynamically sensing its pathology and fixing it.
The Resource Allocation Program, in partnership with many on-campus sources of research funding, facilitates the dissemination, submission, review and award of intramural research funding opportunities on campus.
UCSF researchers have for the first time transformed human stem cells into mature insulin-producing cells, a major breakthrough in the effort to develop a cure for type 1 (T1) diabetes.
